Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-02-13FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for rivastigmine tartrate from Nivagen Pharmaceuticals, Inc., establishing a generic version of ri…
-
FDA approval · 2017-01-27FDA Approved: MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's generic memantine and donepezil hydrochlorides extended-release combination for the treatment of Alzheimer's disease.
-
FDA approval · 2016-11-21FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for VIZAMYL (Flutemetamol F-18) from GE Healthcare, updating its regulatory status for this imaging …
-
FDA approval · 2016-11-17FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approved a supplemental application for a generic donepezil hydrochloride tablet from Dr. Reddy's Laboratories Limited, confirming regul…
-
FDA approval · 2016-11-10FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved an Original Application for a generic donepezil hydrochloride product by Unichem Pharmaceuticals (USA), Inc., expanding acc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-08FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride by Macleods Pharmaceuticals Limited.
-
FDA approval · 2016-11-08FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride by Macleods Pharmaceuticals Limited. The approval covers changes request…
-
FDA approval · 2016-11-08FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for donepezil hydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2016-11-02FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for rivastigmine by Sandoz Inc, updating the approval status of this product.
-
FDA approval · 2016-10-12FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved the original application for memantine hydrochloride from Amneal Pharmaceuticals LLC, granting generic approval for this Al…
-
FDA approval · 2016-10-04FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc.'s supplemental application for Donepezil hydrochloride, a generic product, expanding availability …
-
FDA approval · 2016-10-04FDA Approved: DONEPEZIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for a generic donepezil hydrochloride product from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2016-10-04FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' supplemental application for donepezil hydrochloride, a generic version of Aricept, for the …
-
FDA approval · 2016-10-04FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for donepezil hydrochloride filed by Upsher-Smith Laboratories, LLC. This action concerns a gene…
-
FDA approval · 2016-10-04FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (ACI Healthcare USA, Inc.)
The FDA approved a supplemental application for donepezil hydrochloride submitted by ACI Healthcare USA, Inc.
-
FDA approval · 2016-10-03FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (florbetaben F-18) from Lantheus Biosciences Ltd.
-
FDA approval · 2016-09-28FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for memantine hydrochloride (generic memantine), manufactured by Rising Pharma Holdings, Inc.
-
FDA approval · 2016-09-28FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' memantine hydrochloride as a generic drug (ANDA 206028) for the treatment of moderate to severe Alzheime…
-
FDA approval · 2016-09-22FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride (generic) by Macleods Pharmaceuticals Limited, authorizing its marketing…
-
FDA approval · 2016-08-25FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (florbetaben F-18) submitted by Lantheus Biosciences Ltd.
-
FDA approval · 2016-08-05FDA Approved: GALANTAMINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic Galantamine from Aurobindo Pharma Limited.
-
FDA approval · 2016-07-18FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for NAMZARIC (memantine hydrochloride and donepezil hydrochloride) from Allergan, Inc.
-
FDA approval · 2016-06-23FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a generic version of donepezil hydrochloride under an Original Application by Unichem Pharmaceuticals (USA), Inc. for the treat…
-
FDA approval · 2016-06-22FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for AMYVID (florbetapir F 18) filed by Eli Lilly and Company.
-
FDA approval · 2016-06-07FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for Vizamyl (flutemetamol F-18) submitted by GE Healthcare.